Cargando…
Biocompatibility of NeoMTA Plus® versus MTA Angelus as delayed furcation perforation repair materials in a dog model
BACKGROUND: The biocompatibility of NeoMTA Plus® (Avlon BioMed Inc., Bradenton, Fl) as a furcal perforation repair material is not fully understood. This study compares the biocompatibility of Mineral Trioxide Aggregate (MTA Angelus) and NeoMTA Plus® as delayed furcation perforation repair materials...
Autores principales: | Abboud, Khaled M., Abu-Seida, Ashraf M., Hassanien, Ehab E., Tawfik, Hossam M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8045287/ https://www.ncbi.nlm.nih.gov/pubmed/33849516 http://dx.doi.org/10.1186/s12903-021-01552-w |
Ejemplares similares
-
Histopathological Biocompatibility Evaluation of TheraCal PT, NeoMTA, and MTA Angelus in a Murine Model
por: Quiñonez-Ruvalcaba, Francelia, et al.
Publicado: (2023) -
Biocompatibility and bioactive potential of the NeoMTA Plus endodontic bioceramic-based sealer
por: Hoshino, Roberto Alameda, et al.
Publicado: (2020) -
Marginal adaptation, solubility and biocompatibility of TheraCal LC compared with MTA-angelus and biodentine as a furcation perforation repair material
por: Alazrag, M. A., et al.
Publicado: (2020) -
Cytotoxicity of NeoMTA Plus, ProRoot MTA and Biodentine on human dental pulp stem cells
por: Birant, Sinem, et al.
Publicado: (2021) -
Comparative cytocompatibility of the new calcium silicate-based cement NeoPutty versus NeoMTA Plus and MTA on human dental pulp cells: an in vitro study
por: Lozano-Guillén, Ana, et al.
Publicado: (2022)